Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/09/2023 | Talis Biomedical Corp | TLIS | Grant | Stock option (right to buy) | 95k | $0.50 | $47.5k | | 06/09/2023 |
07/16/2022 | Invitae Corp | NVTA | Grant | Common Stock | 45.3k | $0.00 | $0 | | 07/16/2022 |
07/16/2022 | Invitae Corp | NVTA | Grant | Common Stock | 8.5k | $0.00 | $0 | | 07/16/2022 |
07/16/2022 | Invitae Corp | NVTA | Grant | Employee Stock Option (right to buy) | 22.7k | $2.85 | $64.8k | | 07/16/2022 |
07/16/2022 | Invitae Corp | NVTA | Grant | Employee Stock Option (right to buy) | 4.3k | $2.85 | $12.2k | | 07/16/2022 |
06/22/2022 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 104.9k | $8.45 | $886.6k | | 06/22/2022 |
06/10/2022 | Talis Biomedical Corp | TLIS | Grant | Stock Option (right to buy) | 95k | $1.00 | $95k | | 06/10/2022 |
06/17/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 38.9k | $62.63 | $2.4M | | 06/17/2021 |
05/17/2021 | Talis Biomedical Corp | TLIS | Purchase | Common stock | 11k | $10.11 | $111.2k | | 05/14/2021 |
05/14/2021 | Talis Biomedical Corp | TLIS | Purchase | Common stock | 9k | $10.16 | $91.4k | | 05/14/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Common Stock | 752.9k | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Common Stock | 334.5k | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Common Stock | 302.6k | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Purchase | Common Stock | 312.5k | $16.00 | $5M | By OG Family Trust, u/d/t May 30, 2014 | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Series D-1 Preferred Stock | 1.1M | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Series E-1 Preferred Stock | 478.4k | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | Talis Biomedical Corp | TLIS | Conversion | Series F-1 Preferred Stock | 432.7k | $0.00 | $0 | By Thinking Bench Capital, LLC | 02/17/2021 |
02/17/2021 | BridgeBio Pharma, Inc. | BBIO | Purchase | Common Stock | 16k | $62.50 | $1000k | | 02/17/2021 |
06/23/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 101.2k | $32.62 | $3.3M | | 06/23/2020 |
08/26/2019 | Invitae Corp | NVTA | Sale | Common Stock | 11.7k | $24.02 | $281k | By OG Family Trust | 08/26/2019 |
08/26/2019 | Invitae Corp | NVTA | Sale | Common Stock | 28.3k | $24.82 | $702.4k | By OG Family Trust | 08/26/2019 |
05/28/2019 | Invitae Corp | NVTA | Sale | | 30k | $17.60 | $528k | By OG Family Trust | 05/28/2019 |
05/02/2019 | Invitae Corp | NVTA | Grant | Stock Option (right to buy) | 10k | $24.16 | $241.6k | | 05/02/2019 |
02/25/2019 | Invitae Corp | NVTA | Sale | | 1000 | $19.66 | $19.7k | By OG Family Trust | 02/25/2019 |
02/25/2019 | Invitae Corp | NVTA | Sale | | 29k | $19.08 | $553.3k | By OG Family Trust | 02/25/2019 |
06/22/2018 | Invitae Corp | NVTA | Grant | Employee Stock Option (right to buy) | 10k | $8.08 | $80.8k | | 06/22/2018 |
04/02/2018 | Invitae Corp | NVTA | Purchase | Common Stock | 44.4k | $4.50 | $200k | Randall W. Scott and Eileen M. Scott, Trustees of the OG Family Trust | 04/02/2018 |
05/02/2017 | Invitae Corp | NVTA | Grant | Employee Stock Option (right to buy) | 10k | $11.13 | $111.3k | | 05/02/2017 |
11/22/2016 | Invitae Corp | NVTA | Purchase | Common Stock | 66.7k | $6.00 | $400k | | 11/22/2016 |
02/18/2015 | Invitae Corp | NVTA | Conversion | Common Stock | 3.4M | $0.00 | $0 | | 02/18/2015 |
02/18/2015 | Invitae Corp | NVTA | Conversion | Series C Preferred Stock | 15.7M | $0.00 | $0 | | 02/18/2015 |
02/18/2015 | Invitae Corp | NVTA | Conversion | Series E Preferred Stock | 3.9M | $0.00 | $0 | | 02/18/2015 |
02/18/2015 | Invitae Corp | NVTA | Conversion | Series F Preferred Stock | 1000k | $0.00 | $0 | | 02/18/2015 |
07/11/2012 | GENOMIC HEALTH INC | GHDX | Sale | | 14.7k | $34.79 | $511.5k | | 07/10/2012 |
07/11/2012 | GENOMIC HEALTH INC | GHDX | Sale | | 300 | $35.52 | $10.7k | | 07/10/2012 |
|